New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Brought to you by 
GSK buys Corixa
May 2005
Executive Summary
GlaxoSmithKline PLC has agreed to acquire the 92% of its long-time partner, immunotherapeutics company Corixa, it does not already own. The company is paying £2.31 ($4.40) in cash for each of Corixa's common shares or common-share equivalents (a 52% premium to the market average), or about $300mm. It will also assume $100mm of Corixa's outstanding convertible notes (due 2008).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
- Includes Contract
- Payment Includes Cash
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GSK buys Corixa
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice